ArticleInternational review of financial analysis2022
The impact and role of COVID-19 uncertainty: A global industry analysis.
Article in International review of financial analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Recent advances in TiNanoscale advances · 2026Review
- The Group Intertemporal Decision-Making Process.Behavioral sciences (Basel, Switzerland) · 2024Review
- Experiences of family caregivers of nurses infected with COVID-19: a qualitative study.BMC nursing · 2024Article
- The impact of COVID-19 on firm risk and performance in MENA countries: Does national governance quality matter?PloS one · 2023Article
- A mini-review on how the COVID-19 pandemic affected intertemporal choice.Psychoradiology · 2023Review
- COVID-19 and finance scholarship: A systematic and bibliometric analysis.International review of financial analysis · 2023Article
- Urban park use and self-reported physical, mental, and social health during the COVID-19 pandemic: An on-site survey in Beijing, China.Urban forestry & urban greening · 2023Article
- How does China's stock market react to supply chain disruptions from COVID-19?International review of financial analysis · 2022Article
- The association of COVID-19 nexus on China's economy: A financial crisis or a health crisis?PloS one · 2022Article
- Typologies of people's preexisting political ideology and values would determine their post-pandemic mental health and political behaviors: Evidence from China.Frontiers in psychology · 2022Article
- COVID-19 Pandemic and firm-level dynamics in the USA, UK, Europe, and Japan.International review of financial analysis · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The novel 2019 coronavirus (COVID-19) has resulted in uncertainty that permeates every aspect of life and business. In this study we undertake a comprehensive analysis of the impact of COVID-19 related uncertainty on global industry returns and volatility using a sample of 68 global industries and Google Trends search data to measure COVID-19 related uncertainty. The results indicate that COVID-19 related uncertainty negatively impacts returns on all industries and generally leads to higher volatility. We interpret these findings as uncertainty related to the future financial performance of firms and emerging opportunities for some industries. Certain industries are more resilient than others and increased uncertainty is not only necessarily associated with industries that experienced the largest negative returns. We also find that new factors emerged in the return generating process during the COVID-19 period. We show that despite an uncertain climate, some industries performed well, yielding positive cumulative abnormal returns that at times are greater than during the pre-COVID-19 period. The implications of our findings for investors are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.